Dynamic Technology Lab’s Moderna MRNA Stock Holding History

Dynamic Technology Lab’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,958	Closed	-$708K	–	1228
2024 Q2	$708K	Buy	+5,958	New	+$754K	0.08%	403
2024 Q1	–	Sell	-2,014	Closed	-$200K	–	1290
2023 Q4	$200K	Buy	+2,014	New	+$169K	0.02%	877
2023 Q1	–	Sell	-1,327	Closed	-$238K	–	1364
2022 Q4	$238K	Buy	+1,327	New	+$217K	0.02%	857
2022 Q2	–	Sell	-3,221	Closed	-$555K	–	1384
2022 Q1	$555K	Buy	+3,221	New	+$542K	0.07%	532
2021 Q4	–	Sell	-657	Closed	-$253K	–	1359
2021 Q3	$253K	Buy	+657	New	+$242K	0.03%	820
2021 Q2	–	Sell	-6,242	Closed	-$817K	–	1377
2021 Q1	$817K	Buy	+6,242	New	+$905K	0.09%	326
2020 Q3	–	Sell	-6,249	Closed	-$401K	–	1213
2020 Q2	$401K	Buy	+6,249	New	+$342K	0.06%	542

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dynamic Technology Lab's MRNA Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Moderna (MRNA) in Q3 2024, closing a stake of 5,958 shares — an estimated $708K sold.

Dynamic Technology Lab first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $817K in Q1 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

Dynamic Technology Lab reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
Dynamic Technology Lab sold 5,958 Moderna shares in Q3 2024, an estimated $708K.
Dynamic Technology Lab first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
Dynamic Technology Lab's Moderna position peaked at $817K in Q1 2021.
788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.